Variant report
Variant | esv3394063 |
---|---|
Chromosome Location | chr6:140944259-140947157 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190227285 | chr6:140944275-140944276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201506207 | chr6:140944304-140944305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370368166 | chr6:140944393-140944394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569456050 | chr6:140944421-140944422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373637879 | chr6:140944487-140944488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540053088 | chr6:140944495-140944496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570080221 | chr6:140944505-140944506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142684578 | chr6:140944545-140944546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376901100 | chr6:140944594-140944595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370275430 | chr6:140944647-140944648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533898542 | chr6:140944658-140944659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182937637 | chr6:140944664-140944665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535884642 | chr6:140944735-140944736 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529331929 | chr6:140944751-140944752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573747037 | chr6:140944755-140944756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374954014 | chr6:140944774-140944775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs151013347 | chr6:140944777-140944778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549093487 | chr6:140944802-140944803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562680413 | chr6:140944807-140944808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188829419 | chr6:140944831-140944832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs545615348 | chr6:140944851-140944852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531769150 | chr6:140944861-140944862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139788920 | chr6:140944868-140944869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549087846 | chr6:140944870-140944871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546620119 | chr6:140944876-140944877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561701955 | chr6:140944900-140944901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528929056 | chr6:140944945-140944946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550660799 | chr6:140944955-140944956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568994090 | chr6:140944983-140944984 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143191235 | chr6:140944989-140944990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146685490 | chr6:140945052-140945053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566991919 | chr6:140945067-140945068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571910908 | chr6:140945070-140945071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534501394 | chr6:140945126-140945127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555817065 | chr6:140945197-140945198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs113437693 | chr6:140945221-140945222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537867055 | chr6:140945222-140945223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556213808 | chr6:140945261-140945262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs577719335 | chr6:140945285-140945286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9389815 | chr6:140945378-140945379 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs191574661 | chr6:140945403-140945404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368623981 | chr6:140945436-140945437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184067348 | chr6:140945464-140945465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561848747 | chr6:140945487-140945488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528866200 | chr6:140945510-140945511 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544229007 | chr6:140945568-140945569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs375426386 | chr6:140945630-140945631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562525596 | chr6:140945661-140945662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs533048205 | chr6:140945695-140945696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551232817 | chr6:140945715-140945716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Endocrine pancreatic tumor | 17914106 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:140930400-140947200 | Weak transcription | Placenta | Placenta |
2 | chr6:140936800-140945000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr6:140942200-140945400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr6:140944200-140945000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr6:140944400-140945200 | Enhancers | NHEK | skin |
6 | chr6:140944400-140945400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr6:140944400-140945400 | Enhancers | HSMM | muscle |
8 | chr6:140944600-140945600 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr6:140944800-140945000 | Enhancers | NH-A | brain |
10 | chr6:140944800-140945400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
11 | chr6:140944800-140945400 | Enhancers | Fetal Lung | lung |
12 | chr6:140944800-140945600 | Enhancers | Ovary | ovary |
13 | chr6:140944800-140945600 | Enhancers | HMEC | breast |
14 | chr6:140945000-140945600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr6:140945000-140946600 | Weak transcription | NH-A | brain |
16 | chr6:140945400-140945600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
17 | chr6:140945600-140946200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
18 | chr6:140945600-140946600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
19 | chr6:140946200-140946400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
20 | chr6:140946600-140948600 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
21 | chr6:140947000-140948200 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |